Mucormycosis: An 8-year experience of a tertiary care centre in Saudi Arabia

Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes – a tertiary care center experience

“…In our study, there was a male preponderance (58.22 and 64.66% during the 1 st and 2 nd waves respectively) which is consistent with other studies in literature. [15] …”

Mucormycosis in pediatric oncology patients: a hospital outbreak investigation report

“…[ 30 ] According to the anatomic location of the infection, routes of transmission differ, whether by inhalation of the spores as in pulmonary and rhino-orbital infections, or by way of ingestion of foods contaminated with the spores as in gastrointestinal and soft tissue infections. [ 30 , 31 ] Environmental checks and sampling of all possible patients' commonalities is important. Air sampling can be of great value to trace a possible source of the outbreak in addition to checking air ventilatory systems and water leaks or faulty constructions, [ 28 ] to help identify airborne fungal spores.…”

New Insights on Mucormycosis and Its Association With the COVID-19 Pandemic

“…An annual rate of 0.2 cases/100,000 individuals has been reported in Iraq, Jordan and Algeria, and 1.2 cases/100,000 individuals were reported in Qatar [ 44 , 45 ]. Eighteen patients were recognized in another retrospective study carried out at a tertiary care center in the Kingdom of Saudi Arabia from January 2013 to December 2019 [ 46 ]. In Lebanon, incidence has significantly risen from 0.47 cases/10,000 admissions in 2008 to 1.18 cases/10,000 admissions in 2017 [ 47 ].…”